Fidia Expands Share Capital After New Bond Conversion by GGHL

An announcement from Fidia Spa ( (IT:FDA) ) is now available.

Fidia has reported the conversion of three bonds from the fourth tranche of its convertible bond cum warrant deal with Global Growth Holding Limited, at a price of €0.02 per share, resulting in the issue of 1.5 million new shares. These new shares are being admitted directly to trading on the regulated market under an existing prospectus, expanding the company’s free float and reinforcing its equity base.

Following this latest conversion, the POC has been subscribed for a nominal €1 million, with €870,000 of the related capital increase already subscribed and 13 bonds still to be converted. The partial capital increase of €30,000 brings Fidia’s share capital to €10,717,761.90 and its total share count to 46,542,927, signalling continued execution of its structured financing plan with potential implications for existing shareholders through further dilution as remaining bonds are converted.

The most recent analyst rating on (IT:FDA) stock is a Sell with a EUR0.11 price target. To see the full list of analyst forecasts on Fidia Spa stock, see the IT:FDA Stock Forecast page.

More about Fidia Spa

Fidia S.p.A., based in Turin and listed on Euronext Milan, is a leading provider of numerical controls, high-speed integrated milling systems and CAM software for complex shapes. Its technology is used mainly in mould production for the automotive industry and in aerospace applications, and the group employs around 135 people with a fully integrated offering across the milling process.

Average Trading Volume: 1,346,055

Technical Sentiment Signal: Strong Sell

Current Market Cap: €757.2K

Find detailed analytics on FDA stock on TipRanks’ Stock Analysis page.